NCT05465213View on ClinicalTrials.gov

Real-world Dapagliflozin Treatment in Patients With Heart Failure in Portugal (EVOLUTION-HF)

CompletedOBSERVATIONAL

Enrollment

283

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

June 24, 2024

Study Completion Date

June 24, 2024

Conditions

Heart Failure

Trial Locations (8)

Unknown

Research Site, Almada

Research Site, Amadora

Research Site, Coimbra

Research Site, Lisbon

Research Site, Penafiel

Research Site, Porto

Research Site, Setúbal

Research Site, Vila Real

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY